Oxford Symposia - 6th Annual


Antisense & Therapeutic Nucleic Acids

30-31 March, St Hilda's College, Oxford, UK

Twitter: @LPMHealthcare, #OligoOx20

Welcome to OLIGO 2020 Oxford

This meeting will be held virtually on 03rd December 2020. For further information please visit this link.

Web: http://lpmhealthcare.com/oligo-2020-oxford-virtual


Event Cancellation/Postponement Notice

Our ‘force majeure’ refund policy

We are delighted to announce our 6th annual Oxford Symposium on antisense and therapeutic oligonucleotides.

The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics (see confirmed speakers).

The symposium agenda topics will include THERAPEUTIC APPLICATIONS AND DELIVERY STRATEGIES of synthetic oligonucleotides, including:

>Antisense & catalytic oligonucloetides, aptamers, siRNAs, miRNAs, antagomirs
>Chemical modifications
>In vitro/in vivo applications
>Delivery strategies
>New technologies

We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. Please contact us on OLIGOMER@LPMHealthcare.com with your presentation theme/abstract for pre-approval, or if you have any other questions. Please use this Abstract Template if you are submitting an abstract.

The Symposium will be co-hosted with our 7th annual aptamers symposium and exhibition, Aptamers 2020 (separate registration required).

Scientific Advisers

Dr Marcel Hollenstein, Pasteur Institute, France
Dr Sylvain Ladame, Imperial College London, UK
Dr Simon Richardson, University of Greenwich, UK
Dr Muhammad Sohail, University of Oxford, UK